News/ News/ Oncology GSK joins with US biotech to toughen up cell therapies for solid tumours Richard Staines cancer, cancer cell therapy 0 Comment GlaxoSmithKline has announced a five-year collaboration with San Francisco biotech Lyell Immunopharma, to strengthen therapeutic T-cells before they Share X GSK joins with US biotech to toughen up cell therapies for solid tumours https://pharmaphorum.com/news/gsk-joins-with-us-biotech-to-toughen-up-cell-therapies-for-solid-tumours/
